Molecular signatures of SARS-CoV2 in vitro infection of bronchial epithelium from CF, COPD and healthy subjects
L. Guillot (Paris, France), J. Oliva (Lyon, France), M. Ruffin (Paris, France), C. Calmel (Paris, France), H. Corvol (Paris, France), O. Terrier (Lyon, France)
Source: International Congress 2022 – Lung or long COVID: emerging insights into COVID-19 mechanisms
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Guillot (Paris, France), J. Oliva (Lyon, France), M. Ruffin (Paris, France), C. Calmel (Paris, France), H. Corvol (Paris, France), O. Terrier (Lyon, France). Molecular signatures of SARS-CoV2 in vitro infection of bronchial epithelium from CF, COPD and healthy subjects. 3780
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|